baber/WOPTO huggingface dataset:
Patent AU-2015233334-B2 (AU)
Title: Machine for blow-moulding articles such as containers
Inventor: ELEFTHERIOU STYLIANOS
IPC: B29C49/42
Filed: 2015-03-20
Granted: 2018-12-13
Abstract: Machine for blow-moulding articles from a strip of material (100), comprising a structure (1) on which two chassis (11, 22) are mounted, these each being connected to a displacement actuator so that they can each be moved along a path of the strip between an upstream position and a downstream position with reference to a direction in which the strip travels through the machine, a rod (3), a retaining member and a mould (8) being mounted respectively on the structure and on the chassis (11, 22), and a control unit being connected to the displacement actuators in order to command these so as to bring about a sequence whereby the guide rod (3) and the mould (8) are moved relative to the retaining and mould-opening and closing member so as to cause the strip to advance along the straight path.
Patent AU-2015252137-B2 (AU)
Title: Compositions and methods for diagnosing and treating kidney disorders in a feline
Inventor: AL-MURRANI SAMER WALEED
IPC: G01N33/68
Filed: 2015-11-06
Granted: 2016-04-28
Abstract: The present invention provides a method of diagnosing the existence of a kidney disorder in a feline comprising measuring the level of expression of one or more biomarkers selected from the group consisting of lumican; collagen alpha 1(III) chain, variant 12; decorin; secreted frizzled-related protein 2; retinol binding protein 5; MMP-2; MMP-7; and MMP-19, in a biological sample from the feline, wherein differences in expression of the one or more biomarkers in the sample relative to a control value for expression in a sample from a normal animal indicate the existence of a kidney disorder; a method of treating a feline so diagnosed; and compositions, reagents and kits for carrying out the specified methods.
Patent AU-2015266586-B2 (AU)
Title: Methods and systems for generating virtual content display with a virtual or augmented reality apparatus
Inventor: TEKOLSTE ROBERT D
IPC: G02B30/26
Filed: 2015-05-29
Granted: 2020-07-23
Abstract: Several unique configurations for interferometric recording of volumetric phase diffractive elements with relatively high angle diffraction for use in waveguides are disclosed. Separate layer EPE and OPE structures produced by various methods may be integrated in side-by-side or overlaid constructs, and multiple such EPE and OPE structures may be combined or multiplexed to exhibit EPE/OPE functionality in a single, spatially-coincident layer. Multiplexed structures reduce the total number of layers of materials within a stack of eyepiece optics, each of which may be responsible for displaying a given focal depth range of a volumetric image. Volumetric phase type diffractive elements are used to offer properties including spectral bandwidth selectivity that may enable registered multi-color diffracted fields, angular multiplexing capability to facilitate tiling and field-of-view expansion without crosstalk, and all-optical, relatively simple prototyping compared to other diffractive element forms, enabling rapid design iteration.
Patent AU-2015284385-B2 (AU)
Title: Analogs of pridopidine, their preparation and use
Inventor: SCHMIDT MALLE
IPC: A61K31/451
Filed: 2015-06-29
Granted: 2021-01-21
Abstract: This invention provides an isolated compound having the structure: The invention also provides for a process for preparing 4-(3-(methylsulfonyl)phenyl)-1-propylpiperidin-4-ol, 1-(3,3-bis(3-(methylsulfonyl)phenyl)propyl)-4-(3-(methylsulfonyl) phenyl)piperidone, 1,4-bis((3-(1 -propylpiperidin-4-yl)phenyl)sulfonyl)butane, (3R,4S)-4-(3-(methylsulfonyl)phenyl)-1-propylpiperidin-3-ol, 4-(3-(methylsulfonyl)phenyl)-l-propylpiperidine 1- oxide, 1-(2-methylpentyl)-4-(3-(methylsulfonyl)phenyl)piperidine, 4-(3-(methylsulfinyl)phenyl)-1-propyl-1,2,3,6-tetrahydropyridine, and 4-(3-(methylsulfonyl)phenyl)-1-propyl-1,2,3,6-tetrahydropyridine. This invention also provides an impurity or a salt thereof for use, as a reference standard to detect trace amounts of the impurity in a pharmaceutical composition comprising pridopidine or a pharmaceutically acceptable salt thereof. This invention further provides a process for producing a pridopidine drug product comprising obtaining a pridopidine drug substance and mixing the pridopidine drug substance with suitable excipients so as to produce the pridopidine drug product. This invention also provides a process for producing a pridopidine drug product. This invention also provides a process of distributing a pridopidine drug product.
Patent AU-2015289021-B2 (AU)
Title: Recovery of wood acetylation fluid
Inventor: BENSTEAD STEPHEN JOHN
IPC: B08B3/06
Filed: 2015-07-17
Granted: 2020-07-09
Abstract: Disclosed is the integration of the production of acetic anhydride from ketene, and the acetylation of wood using acetylation fluid comprising acetic acid and acetic anhydride. The invention involves recovering acetylation fluid from wood acetylation, and sending this to an acetic anhydride distillation unit belonging to the acetic anhydride production plant.
Patent AU-2015347886-B2 (AU)
Title: Method of producing lipid using acyl-acp thioesterase
Inventor: OZAKI TATSURO
IPC: C12N1/15
Filed: 2015-11-06
Granted: 2019-07-18
Abstract: [Problem] To provide a method for producing a lipid, said method improving productivity for a medium-chain fatty acid or a lipid having said fatty acid as a constituent. [Solution] Provided is a method for producing a lipid whereby a transformant, which is obtained by the introduction, into a host, of a gene that codes any one of the belowmentioned proteins (A)-(C), is cultured, and a lipid is collected from the culture. (A) A protein that comprises a SEQ ID NO: 1 91
Patent AU-2015377940-B2 (AU)
Title: Support for tensioned screening media
Inventor: MALMBERG MATS
IPC: B07B1/46
Filed: 2015-01-16
Granted: 2018-07-12
Abstract: An elongate capping (102) to support cross-tensioned or pre-tensioned screening media (100) at a screen deck. The capping (102) comprises a pair of arms (105) to grip a carrier beam (101) of the screen deck and a head (104) attached to the arms (105) via a neck (301) wherein the head (104) comprises flexible widthwise extending flanges (302) that are configured to bend and compress towards the arms (105) to support the screening media when mounted on the head (104) under tension.
Patent AU-2015387168-B2 (AU)
Title: Autonomous floor cleaning with a removable pad
Inventor: LU PING-HONG
IPC: A47L11/24
Filed: 2015-11-18
Granted: 2020-07-16
Abstract: An autonomous floor cleaning robot includes a robot body defining a forward drive direction, a controller supported by the robot body, a drive supporting the robot body and configured to maneuver the robot across a surface in response to commands from the controller, a pad holder disposed on an underside of the robot body and configured to retain a removable cleaning pad during operation of the cleaning robot; and a pad sensor arranged to sense a feature of a cleaning pad held by the pad holder and generate a corresponding signal. The controller is responsive to the signal generated by the pad sensor, and configured to control the robot according to a cleaning mode selected from a set of multiple robot cleaning modes as a function of the signal generated by the pad sensor.
Patent AU-2016202296-B2 (AU)
Title: Antimicrobial Agents
Inventor: LAVIGNE ROB
IPC: C12N9/50
Filed: 2016-04-13
Granted: 2017-12-21
Abstract: The present invention relates to antimicrobial agents against Gram-negative bacteria, in particular to fusion proteins composed of an enzyme having the activity of degrading the cell wall of Gram-negative bacteria and a peptide stretch fused to the enzyme at the N- or C 5 terminus. Moreover, the present invention relates to nucleic acid molecules encoding said fusion protein, vectors comprising said nucleic acid molecules and host cells comprising either said nucleic acid molecules or said vectors. In addition, the present invention relates to said fusion protein for use as a medicament, in particular for the treatment or prevention of Gram negative bacterial infections, as diagnostic means or as cosmetic substance. The present 10 invention also relates to the treatment or prevention of Gram-negative bacterial contamination of foodstuff, of food processing equipment, of food processing plants, of surfaces coming into contact with foodstuff, of medical devices, of surfaces in hospitals and surgeries. Furthermore, the present invention relates to a pharmaceutical composition comprising said fusion protein.
Patent AU-2016203633-B2 (AU)
Title: An ostomy bag with a filter construction
Inventor: SCHERTIGER LARS OLAV
IPC: A61F5/441
Filed: 2016-05-31
Granted: 2017-07-06
Abstract: An ostomy appliance comprising a pouch and a filter construction is provided. The filter construction has a first and second foil layer to provide an enclosure for the elements in the filter construction. The filter construction is attached inside the pouch so that the filter construction is free-hanging inside the pouch. The two foil layers may be generally parallel with the walls of the ostomy bag. The foil layers are provided with numerous holes functioning as gas-inlets for the filter construction. The filter construction includes a pre-filter element and a deodorising filter. A method for collecting discharge as well as an ostomy appliance is provided. A method for reducing the number of balloonings and an ostomy appliance for reducing the number of balloonings is also provided. A method of increasing the time to a ballooning as well as an ostomy appliance for increasing the time to ballooning is also provided. 1 3 1 2 5 1 1 0 1 3 1 12 5 >1 12 Fig. 2 Fig. 3
Patent AU-2016204669-B2 (AU)
Title: A fryer
Inventor: ELSENDOORN PETER
IPC: A47J37/12
Filed: 2016-07-06
Granted: 2021-07-01
Abstract: A FRYER 
ABSTRACT 
A continuous fryer that includes a vessel (kettle) (11) through which oil (13) flows in a 
predetermined direction (12). An upstream end of the kettle (11) is a flow control device (34) 
that at least aids in maintaining linear flow through the vessel (11) is said predetermined 
direction (12).
332 
23 
18 A 
'I I ¼ 
/ 0*
Patent AU-2016206316-B2 (AU)
Title: Materials and methods to enhance hematopoietic stem cells engraftment procedures
Inventor: PELUS LOUIS M
IPC: A01N65/00
Filed: 2016-07-21
Granted: 2018-07-12
Abstract: This disclosure is directed to the methods of enhancing hematopoietic stem cells (HSPC) and progenitor cell (HSPC) engraftment procedure. Treatment in vivo of a HSPC donor with compounds that reduce PGE2 biosynthesis or PGE2 receptor antagonists alone, or in combination with other hematopoietic mobilization agents such as AMD3 100 and G-CSF, increases the circulation of available HSPCs. Compounds that reduce the cellular synthesis of PGE2 include non-steroidal anti-inflammatory compounds such as indomethacin. Treatment ex vivo of HSPC with an effective amount of PGE2 or at least one of its derivatives such as 16,16-dimethyl prostaglandin E2 (dmPGE 2), promotes HSPC engraftment. Similar methods may also be used to increase viral-mediated gene transduction efficacy into HSPC.
Patent AU-2016213926-B2 (AU)
Title: Endoscopic Suturing System
Inventor: MITELBERG VLADIMIR
IPC: A61B17/04
Filed: 2016-08-15
Granted: 2017-11-02
Abstract: A treatment device for use with an endoscope having a instrument channel for passage of an endoscopic instrument and a distal end is provided. The treatment device includes an end effector assembly with a base for placement at the distal end of the endoscope, an end effector rotatable relative to the base, and a mounting portion for attaching the base to the endoscope. The mounting portion is resiliently compressible and can be radially compressed for insertion into the instrument channel, whereby an expansion force of the resiliently compressed mounting portion retains the base relative to the distal end of the endoscope. The mounting portion also includes an opening longitudinally extending therethrough and communicable with the instrument chann 1 and sized for receiving an endoscopic instrument therethrough.
Patent AU-2016229982-B2 (AU)
Title: Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
Inventor: MANTZOROS CHRISTOS
IPC: A61K31/47
Filed: 2016-03-07
Granted: 2020-06-18
Abstract: The present invention relates to methods for treating a disease associated with insulin resistance selected from a nonalcoholic fatty liver disease (NAFLD) and its sequelae, a lipodystrophic syndrome or a combination thereof with the selecti ve PPARy agonist INT 131. and optionally vitamin E or compositions thereof. NAFLBs that may be treated with methods and compositions of the present invention include, but are not limited to, simple nonalcoholie fatty liver and nonalcoholic steatohepatitis (NASH), Lipodystrophic syndromes that may be treated with the methods and compositions of the present invention include, but are not limited to, generalized lipodystrophy including congenital generalized lipodystrophy and acquired generalized lipodystrophy and/or partial lipodystrophy, including congenital partial lipodystrophy and acquired partial lipodystrophy, ail of which may or may not include hyperllpidemia and/or hyperglycemia and may or may not include NAFLD.
Patent AU-2016256776-B2 (AU)
Title: Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
Inventor: SCHULER CARLOS
IPC: A61K9/12
Filed: 2016-11-10
Granted: 2018-04-12
Abstract: Methods of treating atrial arrhythmia include administering an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof, such that the at least one antiarrhythmic pharmaceutical agent first enters the heart through the pulmonary vein to the left atrium. Other methods of treating atrial arrhythmia include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. An amount of the at least one antiarrhythmic pharmaceutical agent may peak in the coronary sinus of the heart at a time ranging from 10 seconds to 30 minutes from initiation of the administering. Unit doses, aerosols, and kits are also contemplated.
Patent AU-2016281662-B2 (AU)
Title: Methods and apparatus for conditioning cell populations for cell therapies
Inventor: COX CHARLES S
IPC: C12M3/00
Filed: 2016-06-23
Granted: 2021-12-02
Abstract: A bioreactor system for conditioning of pluripotent cells or cell media is provided. In further aspects, conditioned pluripotent cells and methods for making such cells are provided.
Patent AU-2016297890-B2 (AU)
Title: Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
Inventor: AVERBACK PAUL
IPC: A61P35/00
Filed: 2016-07-25
Granted: 2021-08-19
Abstract: The embodiments include methods of treating conditions requiring removal or destruction of cellular elements, such as benign or malignant tumors using compounds based on small peptides in combination with additional active agent(s). The method includes, but is not limited to, administering the compounds intramuscularly, orally, intravenously, intrathecally, intratumorally, intranasally, topically, transdermally, etc., either alone or conjugated to a carrier to a mammal in need thereof. Carrying out the method unexpectedly reduces the need for subsequent invasive surgical intervention.
Patent AU-2016321238-B2 (AU)
Title: Systems and methods for processing orders for structural designs
Inventor: GRIVETTI TAZIO S
IPC: G06Q30/06
Filed: 2016-09-08
Granted: 2022-04-28
Abstract: A method (700) includes receiving a plurality of design files at a computer-based system (600), wherein each of the design files is indicative of a respective structural design (404), a structural value associated with the respective structural design (404), and a source identifier associated with a designer of the respective structural design (404); causing a graphical representation of at least a portion of the structural designs (404) to be displayed to a user; receiving a user selection of a first structural design (404) of the displayed structural designs (404); generating an additive manufacturing file indicative of the first structural design (404) in a predefined format, wherein the predefined format enables the processing of the additive manufacturing file into a physical structure through an additive manufacturing process; transmitting the selected first structural design (404) in the predefined format; and determining, by the computer based system, a royalty value associated with the selected first structural design (404) based at least on the structural value, the source identifier, and one or more additional parameters.
Patent AU-2016382393-B2 (AU)
Title: Triple glucagon/GLP-1/GIP receptor agonist
Inventor: OH EUH LIM
IPC: A61K38/26
Filed: 2016-12-30
Granted: 2019-07-04
Abstract: The present invention relates to a triple activator which activates glucagon, GLP-1 and GIP receptor and to the applications of the triple activator.
Patent AU-2017201534-B2 (AU)
Title: Toolless blade release mechanism for a power tool
Inventor: SCOTT ZACHARY
IPC: B25F5/00
Filed: 2017-03-07
Granted: 2018-02-01
Abstract: An oscillating power tool having a motor, a base flange driven about an output axis by the motor, and an accessory shaft movable relative to the base flange between a clamping position and a release position. A clamping flange is pivotably coupled to the accessory shaft for clamping an accessory in cooperation with the base flange. 8804827_1 (GHMattes) P105409.AU 48 --- 92 - 45 "C 38 1 39 sB4 38 40"
Patent AU-2017203631-B2 (AU)
Title: Database system with database engine and separate distributed storage service
Inventor: GUPTA ANURAG WINDLASS
IPC: G06F16/23
Filed: 2017-05-30
Granted: 2019-02-07
Abstract: TITLE: DATABASE SYSTEM WITH DATABASE ENGINE AND SEPARATE DISTRIBUTED STORAGE SERVICE A database system may include a database service and a separate distributed storage service. The database service (or a database engine head node thereof) may be responsible for query parsing, optimization, and execution, transactionality, and consistency, while the storage service may be responsible for generating data pages from redo log records and for durability of 0 those data pages. For example, in response to a write request directed to a particular data page, the database engine head node may generate a redo log record and send it, but not the data page, to a storage service node. The storage service node may store the redo log record and return a write acknowledgement to the database service prior to applying the redo log record. The server node may apply the redo log record and other redo log records to a previously stored version of 5 the data page to create a current version.
Patent AU-2017214260-B2 (AU)
Title: Water systems
Inventor: BRIDGES MAXWELL STEPHEN
IPC: F24D19/10
Filed: 2017-02-02
Granted: 2022-08-25
Abstract: A circulating hot water system has a hot water flow circuit defined by pipework leading out from and back to an in-line heater (20), and including a pump (8) to drive circulation of the hot water. Each of multiple user points (4) has an outflow branch conduit (141) and a return flow branch conduit (142) with a common wall for heat exchange, as does the main flow circuit: the outflow conduit surrounds the return conduit. Water is fed into the system from a pressurised cold water supply main (100) through a check valve (110). Sensors are used to monitor water temperatures and flow conditions around the system. A programmed control processor (7) can control heating and pumping rates in various regimes, e.g. to maintain system temperature above a predetermined threshold. An isolation valve adapted for concentric double pipes is also described.
Patent AU-2017237356-B2 (AU)
Title: Method and system for liquefying a natural gas feed stream
Inventor: ARNAIZ DEL POZO CARLOS
IPC: F25J1/02
Filed: 2017-03-20
Granted: 2019-12-05
Abstract: The invention relates to a method of liquefying a natural gas feed stream (1), comprising providing a compressed process stream (25), obtaining a first split-off stream (32) from the compressed process stream and expanding the first split- off stream, cooling a remainder of the compressed process stream (31) against the expanded first split-off stream, obtaining a second split-off stream (52) from the precooled process stream (41) and expanding the second split-off stream, cooling a remainder of the precooled compressed process stream (51) against a vapour stream (56) obtained from the second split-off stream, expanding the further cooled process stream (61) thereby obtaining a liquid natural gas stream (71), passing the first split-off stream (42) and the vapour stream (62) to a recompression stage (200) to obtain a recycle stream (105) to be combined with a natural gas feed stream to form the process stream.
Patent AU-2017267726-B2 (AU)
Title: Assay for determining the total carbonylation level on a polypeptide
Inventor: MAH ANNA
IPC: G01N33/50
Filed: 2017-05-18
Granted: 2023-09-14
Abstract: The description relates to a method and kits for determining the total carbonylation level on a polypeptide.
Patent AU-2017274068-B2 (AU)
Title: Process and apparatus for disbudding and inhibiting horn growth
Inventor: STEINFORT JOHN JAMES
IPC: A01K17/00
Filed: 2017-06-01
Granted: 2023-02-02
Abstract: A method of inhibiting the growth of a horn or a horn bud in a livestock animal including the steps of applying a cryogenic fluid around the base of the horn or on the horn bud using an apparatus; such that the cryogenic fluid contacts the base of the horn and epidermal skin layers that surrounds the horn or horn bud and induces a freeze in said layers to inhibit or prevent any further growth of the horn or horn bud.
Patent AU-2017278099-B2 (AU)
Title: Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same
Inventor: VERDIN ERIC
IPC: G02B1/08
Filed: 2017-06-02
Granted: 2021-03-11
Abstract: Aspects of the present disclosure include fatty acid β-hydroxyester compounds (e.g., fatty acid esters of β-hydroxybutyrate), fatty acid esters of butanediol, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions having one or more fatty acid β-hydroxyester compounds and/or one or more fatty acid esters of butanediol. Methods for treating a subject by administering one or more esters to the subject are also provided. Kits containing one or more of the subject esters are also described.
Patent AU-2017293369-B2 (AU)
Title: Mirror having an integrated electronic display
Inventor: DUNN WILLIAM
IPC: G09F13/04
Filed: 2017-06-29
Granted: 2019-11-28
Abstract: An apparatus for presenting an image on a mirrored display 100 includes an electronic display 104 having backlight and a viewing area. A cover glass 204 has a surface area is positioned in front of and substantially parallel with the electronic display 104 such that the surface area substantially covers the viewing area. A reflective layer 205 located on and substantially coextensive with said cover glass 204 is partially silvered where the reflective layer 205 is located above the viewing area and substantially fully silvered on the remaining surface thereof.